Notartomaso, S., Zappulla, C., Biagioni, F., Cannella, M., Bucci, D., Mascio, G., . . . Nicoletti, F. (2013). Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. Mol Brain.
Παραπομπή Chicago StyleNotartomaso, Serena, et al. "Pharmacological Enhancement of MGlu1 Metabotropic Glutamate Receptors Causes a Prolonged Symptomatic Benefit in a Mouse Model of Spinocerebellar Ataxia Type 1." Mol Brain 2013.
Παραπομπή MLANotartomaso, Serena, et al. "Pharmacological Enhancement of MGlu1 Metabotropic Glutamate Receptors Causes a Prolonged Symptomatic Benefit in a Mouse Model of Spinocerebellar Ataxia Type 1." Mol Brain 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.